In Search of New Painkillers

Jülich neuroscientists are partners in a research project aiming to support the development of new painkillers

Jülich/Aachen, 16 November 2017 – Drug development entails huge challenges, particularly when the aim is to find solutions for patients whose pain cannot be adequately treated with current medications. Complex disease mechanisms must be clarified and improved drugs developed. Neuroscientists from Forschungszentrum Jülich are involved in the project entitled “Development of PET-ligands to demonstrate the duality of the mechanisms of action of new analgesics” (Dual2PET), which aims to support the development of new drugs with dual mechanisms of action for chronic pain which is currently difficult to treat. The State of North Rhine-Westphalia selected the project for funding within the LifeSciences.NRW lead market competition. Dual2PET will receive € 2 million over three years from the European Regional Development Fund and the State of North Rhine-Westphalia.

read more (in German)

Last Modified: 22.05.2022